Sinclair Pharma (XPAR:SPH) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma ROE % Adjusted to Book Value?

Sinclair Pharma's ROE % for the quarter that ended in Jun. 2018 was -24.51%. Sinclair Pharma's PB Ratio for the quarter that ended in Jun. 2018 was N/A. Sinclair Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2018 was N/A.

Sinclair Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Sinclair Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma ROE % Adjusted to Book Value Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.37

-16.70

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sinclair Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinclair Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's ROE % Adjusted to Book Value falls into.

Sinclair Pharma ROE % Adjusted to Book Value Calculation

Sinclair Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2017 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-0.03%	/	N/A
	=	N/A

Sinclair Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2018 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-24.51%	/	N/A
	=	N/A

Sinclair Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.